Abstract
Stimulation of spinal muscarinic acetylcholine receptors (mAChRs) produces potent analgesia. Both M2 and M4 mAChRs are coupled to similar G proteins (Gi/o family) and play a critical role in the analgesic action of mAChR agonists. To determine the relative contribution of M2 and M4 subtypes to activation of Gi/o proteins in the spinal cord, we examined the receptor-mediated guanosine 5′-O-(3-[35S]thio)triphosphate ([35S]GTPγS) binding in M2 and M4 subtype knockout (KO) mice. Basal [35S]GTPγS binding in the spinal cord was similar in the wild-type controls, M2 and M4 single-KO, and M2/M4 double-KO mice. The spinal [35S]GTPγS binding stimulated by either muscarine or oxotremorine-M was not significantly different among three groups of wild-type mouse strains. In M2 single-KO and M2/M4 double-KO mice, the agonist-stimulated [35S]GTPγS binding was completely abolished in the spinal cord. Furthermore, the agonist-stimulated [35S]GTPγS binding in the spinal cord of M4 single-KO mice was significantly reduced (∼15%), compared with that in wild-type controls. On the other hand, the spinal [35S]GTPγS binding stimulated by a μ-opioid agonist was not significantly different between wild-type and M2 and M4 KO mice. This study provides complementary new evidence that M2 is the most predominant mAChR subtype coupled to the Gi/o proteins in the spinal cord. Furthermore, these data suggest that a small but functionally significant population of M4 receptors exists in the mouse spinal cord. The functional activity of these M4 receptors seems to require the presence of M2 receptors.
Footnotes
-
This study was supported by the National Institutes of Health Grants NS45602 and GM64830.
-
doi:10.1124/jpet.104.082537.
-
ABBREVIATIONS: mAChR, muscarinic acetylcholine receptor; KO, knockout; [35S]GTPγS, guanosine 5′-O-(3-[35S]thio)triphosphate; GDP, guanosine diphosphate; DAMGO, (d-Ala2, N-Me-Phe4,Gly-ol5)-enkephalin; GTP, guanosine triphosphate; QNB, quinuclidinyl benzilate; WT, wild-type.
- Received December 20, 2004.
- Accepted January 20, 2005.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|










